Lazarus CDS leverages Artificial Intelligence to improve early cancer detection by turning a primary care doctor into a specialist for 5 minutes. For diseases like cervical cancer, this is as simple as a simple prompt that alerts physicians of high-risk patients, enabling them to make better clinical decisions. In skin cancer, we turn any mobile device into an AI-powered dermascope, automatically classifying risk based on a whole host of factors. Best of all, it's fully explainable. No black boxes, just real results.

Lazarus uses patient health data and AI to detect cancer early. The company has clinical decision support systems for skin and cervical cancer, which help improve the diagnostic accuracy of physicians.

Following extensive research, we have built a set of Personalised Support Services for cancer patients. These services are based on research and guidelines and offer evidence-based approaches to improve quality of life, while strengthening the relationship between the patient and their medical team.

They have been built by analysing thousands of scientific publications from high impact factor journals, as well as guidelines, medical literature, and databases. This allows CareAcross to match every patient’s needs with the most appropriate support.

We offer services among the following: 

• Breast cancer
• Lung cancer
• Bowel cancer
• Prostate cancer
• Other cancer types

CareAcross is a digital health company focusing on cancer. It provides 100% personalised support to people affected by cancer through reliable information, useful tools, psychological support & guidance from experts. Its vision is to facilitate faster, more effective oncology research, and interactions that will improve quality of life of patients and caregivers.